Clinical Trial Update: Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the effect of hemodialysis on JTZ-951 in subjects with end-stage renal disease due to anemia of chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• JTZ-951

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Anemia in Chronic Kidney Disease | Phase 1 | Status: COMPLETED